Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ckj/sfw020 http://scihub22266oqcxt.onion/10.1093/ckj/sfw020 C4886915!4886915 !27274824     free     free     free       Clin+Kidney+J 2016 ; 9 (3 ): 403-7 Nephropedia Template TP {{tp|p=27274824 |t=2016. Kidney transplant outcomes in familial C3 glomerulopathy |pdf=|usr=}}{{27274824 }} gab.com Text Kidney transplant outcomes in familial C3 glomerulopathy JO: Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=27274824 #FOAvip C3 glomerulopathy, a newly designated entity, is characterized by glomerular disease associated with dysregulation of the alternative complement pathway and is a rare cause of end-stage kidney disease. Overall disease characteristics that include clinical presentation, laboratory assessment, histopathology and genetic background have only been unravelled in recent years and have led to the development of anti-complement therapies targeting different levels of the alternative pathway. We describe the long-term outcomes following kidney transplantation in an Irish family with familial C3 glomerulopathy due to a hybrid CFHR3-1 gene. Twit Text FOAVip Kidney transplant outcomes in familial C3 glomerulopathy ????Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=27274824 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27274824 #FOAvip English Wikipedia <ref>{{Cite pmid|27274824 }}</ref> Kidney transplant outcomes in familial C3 glomerulopathy #MMPMID27274824 Wong L ; Moran S ; Lavin PJ ; Dorman AM ; Conlon PJ Clin Kidney J 2016[Jun]; 9 (3 ): 403-7 PMID27274824 show ga C3 glomerulopathy, a newly designated entity, is characterized by glomerular disease associated with dysregulation of the alternative complement pathway and is a rare cause of end-stage kidney disease. Overall disease characteristics that include clinical presentation, laboratory assessment, histopathology and genetic background have only been unravelled in recent years and have led to the development of anti-complement therapies targeting different levels of the alternative pathway. We describe the long-term outcomes following kidney transplantation in an Irish family with familial C3 glomerulopathy due to a hybrid CFHR3-1 gene. ?Kidney transplant outcomes in familial C3 glomerulopathy (epmc).pdf DeepDyve Pubget Overpricing